Saturday, March 18, 2006
Forbes magazine: Expectations high for Radford drugmaker
According to a recent Forbes piece, "a lot of people have their fingers crossed" that New River Pharmaceuticals Inc. will successfully launch its planned new treatment for attention-deficit hyperactivity disorder with partner Shire Plc.Full Article
It's interesting to note how fast these ADD/ADHD diagnosis's came about, and how fast the pharmaceutical companies came out with "solutions".
